Providing people with cancer & their oncologists with the best personalized and ranked #cancer treatment options through precision oncology. [email protected]
McLean, VA
Joined March 2013
- Tweets4K
- Following2.7K
- Followers2.5K
- Likes1.7K
We’re delighted to present our new Chief Marketing Officer. She’s an industry veteran who’s excited about driving growth for #Perthera, a pioneer in #PrecisionOncology Decision Support. Read more about Jeanne at perthera.com/news/chief-mark…
#PrecisionMedicine #MedTwitter #AI
It's been an amazing year for #Perthera at #ASCO24! Come to booth 37082 to learn about our patented Artificial Intelligence and how it can help physicians match cancer patients with individualized and optimized treatment options
#PrecisionMedicine #MedTwitter #OncTwitter #AI
It's that time of the year again for #ASCO24 Come find us at booth 37082, just north of the poster section! #ASCO24 #PrecisionMedicine #Perthera #ASCO2024 #MedTwitter #OncoAlert #OncTwitter #GIPOCS
Perthera Names HealthTech and Medical Marketing Veteran, Donna Tuths, as CEO einpresswire.com/article/700… via @ein_news
Part of the #Perthera dream team at #ASCO2023 and #PrecisionMedicine at its finest! 🧬⚕️ @MPishvaian @edikb @parbeloa @albertkelley @NancyTea13 #OncTwitter #OncoAlert #PancreaticCancer #MedTwitter
Come speak with @edikb as he presents our collective research at board 470 at the #ASCO2023 #PosterSession! @MPishvaian @HopkinsMedicine @GeorgeMasonU #GIPOCS #PanCan #PrecisionMedicine #Perthera
Powerful and personal opening statement by @ASCOPres @DrEricWiner yesterday, highlighting the cornerstones of effective cancer care. #ASCO2023 #ASCO23 #PrecisionMedicine
Today, on #NationalCancerSurvivorsDay, let's celebrate the incredible resilience and strength of those who have triumphed over #Cancer. Together, let's support #Survivors and raise awareness about the importance of ongoing research and the power of #PrecisionMedicine. #NCSD2023
Perthera retweeted
Can patients with locally advanced rectal cancer safely avoid radiation and its often serious side effects? @PamelaKunzMD breaks down new data from the PROSPECT trial presented at #ASCO23. See the study results fal.cn/3yO0u
Nearly 50% of pts with mPDAC never receive a 2nd line of therapy for metastatic disease following frontline FFX or GA. Genomic alterations in the DDR pathway (e.g. BRCA1/2) are associated with increased progression-free survival (PFS) on ...👉 tinyurl.com/2jz8nyjq #ASCO23
Validation of the PDACai signature in predicting relative benefit from frontline FOLFIRINOX (FFX) and gemcitabine/nab-paclitaxel (GA) for patients (pts) with metastatic pancreatic cancer (mPDAC). tinyurl.com/2jz8nyjq Visit our poster session #ASCO23 @MPishvaian @edikb
At ASCO '23, AI Precision Oncology Company Perthera Unveils Premium Experience for Clinicians with New Options for... prn.to/43CeR83